APDM was founded with the objective of creating novel technologies to
enable the scientific community to conduct quality research in movement science,
accelerate clinical trials by introducing a new generation of biomarkers and validated endpoints, and
improve the quality of life of people with movement disorders through precision medicine for neurodegenerative diseases.
Longest tenured team in wearable movement science industry
Researchers globally utilizing APDM technology
Gold standard technology for precision motion analytics
Portfolio with patents (sensors, systems, & methods) dating back to 2008
Validated outcomes/endpoints ready for use in your study
World-class scholars in motion science, movement disorders, and biomedical signal processing
APDM, AN ERT COMPANY
ERT, the leader in clinical endpoints data collection, has acquired APDM Wearable Technologies. The combined company will generate higher-fidelity and more powerful data to enable clinical trials to be more predictable, cost-effective, and efficient. Thereby, reinventing endpoint measurement.
APDM’s platform has been validated by the top world researchers for over 10 years and has hundreds of scientific publications and studies validating the technology and outcome measures.
2828 SW Corbett Avenue, Suite 135, Portland, OR 97201